Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 14.

Journal Article

Al-Sawaf, O., Bahlo, J., Fischer, K., Herling, C., M., Hochstaetter, Fink, A. M., von Tresckow, J., Langerbeins, P., Cramer, P., Stilgenbauer, S., Wendtner, C. M., Eichhorst, B., Hallek, M. and Goede, V. (2017). Characteristics, treatment, and outcomes of >= 80 year old patients with chronic lymphocytic leukemia (CLL) enrolled to prospective trials of the German CLL study group. Oncol. Res. Treat., 40. S. 139 - 140. BASEL: KARGER. ISSN 2296-5262

Al-Sawaf, O., Kluth, S., Bahlo, J., Hopfinger, G., Fink, A. M., Cramer, P., Maurer, C., Bergmann, M., Dreyling, M., Lange, E., Kneba, M., Stilgenbauer, S., Kiehl, M. G., Jaeger, U., Wendtner, C. M., Fischer, K., Hallek, M. and Eichhorst, B. (2016). Impact of gender on outcome after chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) or bendamustin plus R (BR) in CLL patients: a pooled analysis of the German CLL Study Group (GCLLSG). Oncol. Res. Treat., 39. S. 212 - 214. BASEL: KARGER. ISSN 2296-5262

Al-Sawaf, O., Robrecht, S., Bahlo, J., Fink, A. M., Cramer, P., Langerbeins, P., von Tresckow, J., Maurer, C., Kutsch, N., Lange, E., Kiehl, M., Fischer, K., Stilgenbauer, S., Wendtner, C-M, Goede, V, Hallek, M. and Eichhorst, B. (2018). Incidence and outcome of Richter transformation in chronic lymphocytic leukaemia (CLL) - A meta-analysis of German CLL Study Group (GCLLSG) trials. Oncol. Res. Treat., 41. S. 166 - 167. BASEL: KARGER. ISSN 2296-5262

Al-Sawaf, O., Robrecht, S., Bahlo, J., Fink, A. M., Cramer, P., Von Tresckow, J., Lange, E., Kiehl, M., Dreyling, M., Ritgen, M., Duerig, J., Tausch, E., Schneider, C., Stilgenbauer, S., Wendtner, C. M., Fischer, K., Goede, V, Hallek, M. and Eichhorst, B. . Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Al-Sawaf, O., Robrecht, S., Bahlo, J., Fink, A. M., Cramer, P., von Tresckow, J., Maurer, C., Bergmann, M., Seiler, T., Lange, E., Kneba, M., Stilgenbauer, S., Doehner, H., Kiehl, M. G., Jaeger, U., Wendtner, C. M., Fischer, K., Goede, V., Hallek, M., Eichhorst, B. and Hopfinger, G. (2017). Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group. Leukemia, 31 (10). S. 2251 - 2255. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Al-Sawaf, O., Robrecht, S., Bahlo, J., Fink, A. M., von Tresckow, J., Cramer, P., Langerbeins, P., Kutsch, N., Wendtner, C. M., Fischer, K., Eichhorst, B., Goede, V. and Hallek, M. (2017). Mode of progression correlates with further clinical outcome of chronic lymphocytic leukemia (CLL). A meta-analysis by the German CLL study group. Oncol. Res. Treat., 40. S. 138 - 139. BASEL: KARGER. ISSN 2296-5262

Edelmann, J., Tausch, E., Landau, D. A., Robrecht, S., Bahlo, J., Fischer, K., Fink, A. M., Bloehdorn, J., Holzmann, K., Boettcher, S., Werner, L., Kneba, M., Gribben, J. G., Neuberg, D. S., Wu, C. J., Hallek, M., Doehner, H. and Stilgenbauer, S. (2017). Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial. Leukemia, 31 (3). S. 734 - 740. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Fink, A. M., Maurer, C., Bahlo, J., Kluth, S., Linde, H., Aldaoud, A., Illmer, T., Dengler, J., Klausmann, M., Lathan, B., Al-Sawaf, O., Fischer, K., Wendtner, C. -M, Eichhorst, B. and Hallek, M. (2016). Three years after the start of enrolment: Current data from the prospective CLL-registry of the German CLL Study Group. Oncol. Res. Treat., 39. S. 256 - 257. BASEL: KARGER. ISSN 2296-5262

Fuerstenau, M., Bahlo, J., Fink, A. M., Lange, E., Dreger, P., Dreyling, M., Hess, G., Ritgen, M., Kneba, M., Doehner, H., Stilgenbauer, S., Wendtner, C. M., Goede, V., Fischer, K., Boettcher, S., Hallek, M. and Eichhorst, B. (2020). Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia. Leukemia, 34 (3). S. 924 - 929. LONDON: SPRINGERNATURE. ISSN 1476-5551

Hallek, M., Fischer, K., Fingerle-Rowson, G., Fink, A. M., Busch, R., Mayer, J., Hensel, M., Hopfinger, G., Hess, G., von Gruenhagen, U., Bergmann, M., Catalano, J., Zinzani, P. L., Caligaris-Cappio, F., Seymour, J. F., Berrebi, A., Jaeger, U., Cazin, B., Trneny, M., Westermann, A., Wendtner, C. M., Eichhorst, B. F., Staib, P., Buehler, A., Winkler, D., Zenz, T., Boettcher, S., Ritgen, M., Mendila, M., Kneba, M., Doehner, H. and Stilgenbauer, S. (2010). Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet, 376 (9747). S. 1164 - 1175. NEW YORK: ELSEVIER SCIENCE INC. ISSN 0140-6736

Kovacs, G., Bahlo, J., Kluth, S., Fink, A. M., Cramer, P., von Tresckow, J., Maurer, C., Langerbeins, P., Gross-Opphoff-Mueller, C., Fischer, K., Wendtner, C. -M., Kreuzer, K. -A., Stilgenbauer, S., Hallek, M., Eichhorst, B. and Goede, V. (2015). Impact and predictors of reducing prescribed doses of fludarabine, cyclophosphamide and rituximab (FCR) in frontline treatment of chronic lymphocytic leukemia (CLL). Oncol. Res. Treat., 38. S. 91 - 92. BASEL: KARGER. ISSN 2296-5262

Langerbeins, P., Busch, R., Schweighofer, C. D., Mueller, C., Cramer, P., Fink, A. M., Faetkenheuer, G., Hartmann, P., Stilgenbauer, S., Boettcher, S., Wendtner, C. M., Hallek, M. and Eichhorst, B. (2014). SEVERE INFECTIONS ARE MORE COMMON IN PHYSICALLY FIT CLL PATIENTS WITH FCR-THERAPY COMPARED TO BR: RESULTS OF THE INTERMIN-ANALYSIS OF THE CLL10 TRIAL OF THE GERMAN CLL STUDY GROUP. Haematologica, 99. S. 55 - 57. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Maurer, C., Fink, A. M., Robrecht, S., Bahlo, J., Fischer, K., Eichhorst, B. and Hallek, M. (2018). First-line treatment and outcome in patients with chronic lymphocytic leukemia (CLL) according to age: a report of the German CLL Study Group (GCLLSG) registry. Oncol. Res. Treat., 41. S. 170 - 172. BASEL: KARGER. ISSN 2296-5262

Maurer, C., Langerbeins, P., Bahlo, J., Cramer, P., Fink, A. M., Pflug, N., Engelke, A., von Tresckow, J., Kovacs, G., Stilgenbauer, S., Wendtner, C-M, Mueller, L., Ritgen, M., Seiler, T., Fischer, K., Hallek, M. and Eichhorst, B. (2016). Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. Leukemia, 30 (10). S. 2019 - 2026. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

This list was generated on Fri Mar 29 08:39:33 2024 CET.